Gastroenterology

Latest News

AI biosimilar syringe | Image credit: Phichaphat - stock.adobe.com
Early Success of Adalimumab Biosimilars Featured at AMCP 2025

April 5th 2025

High adherence rates, comparable clinical effectiveness, and cost savings have marked the early adoption of adalimumab biosimilars in the US, particularly in formulary-driven transitions, as shown in 2 retrospective studies presented at the Academy of Managed Care Pharmacy annual meeting (AMCP 2025).

Biosimilars Gastroenterology Roundup: March 2025
Biosimilars Gastroenterology Roundup: March 2025

April 1st 2025

ibd | Image credit: eddows - stock.adobe.com
Patients With IBD Maintain Therapy 2 Years Post Switching to Infliximab Biosimilar

March 23rd 2025

anti-tnf biologics and savings in Europe | Image credit: gopixa - stock.adobe.com
Smart Tendering Policies Unlock Greater Biosimilar Savings

March 20th 2025

pregnant woman taking biosimilar for IBD | Image credit: pressmaster - stock.adobe.com
Comparable Pregnancy and Infant Milestones With Infliximab Biosimilars vs Originator in IBD

March 15th 2025

Video Series
Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
cfb podcast banner
"When Choice Arrives: Competition & Consequences" written over a bright blue syringe with the AJMC/The Center for Biosimilars logo in the bottom right corner

More News

© 2025 MJH Life Sciences

All rights reserved.